Navigation Links
Reportlinker Adds Global In Vitro Diagnostics (IVD) Market Report: 2010 Edition
Date:9/28/2010

NEW YORK, Sept. 28 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Global In Vitro Diagnostics (IVD) Market Report: 2010 Edition

http://www.reportlinker.com/p0304775/Global-In-Vitro-Diagnostics-IVD-Market-Report-2010-Edition.html

The global IVD market has been experiencing rapid growth, in spite of the economic recession. There has been growing awareness about health and prevention of diseases among the people, which is expected to further boost the industry's performance in the coming years. Furthermore, with countries making their healthcare services more and more accessible to the people, the demand for various IVD devices is increasing.

The developed countries presently account for the bulk of the IVD market. The emerging economies although do not have a major share in the global market, but are expected to grow at faster rate in the future and offer growth opportunities in the global market. The US, Europe and Japan are the main markets for both the pharmaceuticals and IVD industries, controlling more than three-fourth of the global IVD market. In Europe, the largest markets are Germany, followed by Italy and France.

Diabetes has been one of the major segments of the IVD market. Also, diabetes is regarded as one of the fastest growing diseases in the world due to the changing lifestyle of the present era's population.

Demand within the IVD industry has been driven by the ever increasing ageing population, technological advancements and more strict disease control standards in developed countries, amongst others. The emerging economies offer immense opportunities for the further growth of the industry. The increasing insurance facilities are also expected to boost the growth of the industry in the coming years. Complying with the laws and regulations has been one of the major challenges faced by the industry.

The global IVD market has been highly consolidated, with the top eight players accounting for a major share of the market. Roche Holdings is the market leader controlling a major part of the market.

The report analysis the IVD market on a global scale and it also provides detailed information regarding the key regional markets, Europe, US as well as the one of the emerging economies, India. The report analyses the various trends and challenges being faced by the global IVD market. It profiles the four major Pharma players involved in IVD testing: Roche Holdings, Siemens AG, Abbott Laboratories and Beckman Coulter.

By combining SPSS Inc.'s data integration and analysis capabilities with our relevant findings, we have predicted the future growth of the industry. We employed various significant variables that have an impact on this industry and created regression models with SPSS Base to determine the future direction of the industry. Before deploying the regression model, the relationship between several independent or predictor variables and the dependent variable was analyzed using standard SPSS output, including charts, tables and tests.

1. Diagnostics Market

1.1 Overview

1.2 In Vitro Diagnostic

IVD Process

IVD End Users

2. Global IVD Market

Market Value & Growth Rate

Breakdown by Region

Market Segmentation

Key Players by Segments

3. IVD Market - Country Analysis

3.1 Mature Markets

3.1.1 European IVD Market

Market Value

Breakdown by Countries

3.1.2 United States IVD Market

Market Value

Market Segmentation

3.2 Emerging Market

3.2.1 India

Overview

Market Segmentation

4. Market Trends and Drivers

4.1 Market Trends

4.1.1 Industry Consolidation

4.2 Growth Drivers

4.2.1 Ageing Population Worldwide

4.2.2 Demand from the Emerging Economies

4.2.3 Strict Disease Control Standards in Developed Countries

4.2.3 Technological Advancement

4.2.4 Diabetic Population

4.2.5 Increasing Insurance Density

5. Key Challenges

5.1 Stringent Regulations

5.2 Launch of New Products

6. IVD Market - Competitive Landscape

Market Share

Financial Comparison – Revenue, EBIT, Net Margin & EPS

7. Company Profiles

7.1 Roche Holdings AG

Company Overview

Key Financials

Business Strategies

Innovation in Therapeutics & Diagnostics

Personalized Healthcare

7.2 Siemens AG

Company Overview

Key Financials

Business Strategies

Focus on Innovation

Trendsetter in Imaging

7.3 Abbott Laboratories

Company Overview

Key Financials

Business Strategies

Diverse Mix of Business Portfolio

Mergers & Acquisitions

7.4 Beckman Coulter

Company Overview

Key Financials

Business Strategies

Strategic Acquisitions

Expansion of Geographic Reach

8. Market Outlook

8.1 Market Forecast

8.2 Forecast Methodology

8.2.1 Dependent and Independent Variables

8.2.2 Correlation Analysis

8.2.3 Regression Analysis

List of ChartsGlobal IVD Market – Segments by Technology

In Vitro Diagnostics (IVD) Process

IVD Market – End Users

Global IVD Market Size (2002-2009)

Geographical Breakdown of Global Clinical IVD Market (2008)

IVD Growth Rates by Region (2009-2014)

Global IVD Market Segmentation by Technology (2009)

Global IVD Market by Clinical Segments (2008E)

IVD Testing By End User (2008)

IVD Market Size of European Countries (2008)

Vitamin D Penetration per 1000 Inhabitants in Europe (2009)

Vitamin D Market Penetration and Tests in Europe (2009 and 2014)

US Healthcare Expenditure (2001-2009E)

US Diagnostic Testing Market Size by Revenue (2008)

Vitamin D Market Penetration and Tests in the US (2009 and 2014)

Indian IVD Market Segmentation (2007)

India Reagents Market by Segments (2008E)

Ageing Population Worldwide (age>65) 2005-2015

World Population with Diabetes, Age Group 20-79 year (2006-2012)

Global Insurance Density (2003-2009)

Global IVD Market Share by Company (2008)

IVD Market Competitors by Diagnostic Revenue (2008)

IVD Market Competitors Diagnostic Divisional EBIT Margin

Roche Holdings Revenue (2005-2009)

Roche Holdings Revenue by Segments (2009)

Siemens AG Revenue (20055-2009)

Siemens Revenue Breakdown by Segments (2009)

Abbott Laboratories Revenue (2005-2009)

Abbott Laboratories Revenue by Segments (2009)

Beckman Coulter Revenue (2005-2009)

Beckman Coulter Revenue Breakdown by Segments (2009)

Global In Vitro Diagnostic Market in GBP billion (2009-2014E)

Global In Vitro Diagnostics Market in US$ billion (2009-2014E)

List of TablesContributions of IVD

Top 10 Regional IVD Markets (2008 and 2015E)

Global IVD Market by Country (2002-2012E)

IVD Market Key Players by Segments

Country-wise Division of European IVD Market (2008)

Financial Position of Key Players (FY09)

Growth Rates of Key Players (2009-2011E)

Dependent & Independent Variables (2003– 2009)

Correlation Matrix

Model Summary – Coefficient of Determination

Regression Coefficients Output

To order this report:In Vitro Diagnostic Industry: Global In Vitro Diagnostics (IVD) Market Report: 2010 Edition

In Vitro Diagnostic Business News

More Market Research Report

Check our Company Profile, SWOT and Revenue Analysis!CONTACT:Nicolas BombourgReportlinkerEmail: nbo@reportlinker.comUS: (805)652-2626Intl: +1 805-652-2626
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Reportlinker Adds Global Pico Projector By Application, Technology & Products Market (2010-2014)
2. Reportlinker Adds Top 10 Drug Delivery Technologies (2010 - 2015)
3. Reportlinker Adds Medical Magnetic Resonance Imaging (MRI): Technologies and Global Markets
4. Reportlinker Adds Johnson & Johnson: PharmaVitae Profile
5. Reportlinker Adds Bayer Schering Pharma AG: PharmaVitae Profile
6. Reportlinker Adds Genzyme Corporation: PharmaVitae Profile
7. Reportlinker Adds Multiple Sclerosis (MS) Drugs and Biologics: Technologies and Global Markets
8. Reportlinker Adds Spinal Surgical Devices: Technologies and Global Markets
9. Reportlinker Adds Actelion Ltd: PharmaVitae Profile
10. Reportlinker Adds Pfizer Inc.: PharmaVitae Profile
11. Reportlinker Adds Sanofi-Aventis: PharmaVitae Profile
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... , Südkorea, 23. Februar 2017 LG Innotek ... Sterilisationsaufgaben vorgestellt. Die Sterilisationsleistung beträgt das 1,5-fache des 45-mW-Moduls ... Strahlung im Bereich zwischen 200 und 280 nm und eignet ... Bakterien, indem es ihre DNA zerstört. Das Produkt von ... ...
(Date:2/23/2017)... Feb. 23, 2017 ITL Limited, ( ASX: ITD ), ... for the half year ended 31 December 2016 compared with the ... presentation can be viewed here . Highlights ... $1.04m; up 104%) Earnings per share of 2.2 ... of $17.5m (Dec 2015: $15.7m; up 11%) Profit ...
(Date:2/23/2017)... 2017 Research and Markets has announced the addition ... report to their offering. ... The latest research Menopause Drugs Price Analysis and Strategies - 2016, provides ... research answers the following questions: What are ... they positioned in the Global Menopause market? What are ...
Breaking Medicine Technology:
(Date:2/26/2017)... ... 2017 , ... Occupational pesticide exposure is linked to an ... according to a study released today at the 1st Pan American Parkinson’s and ... pesticides and incidence of sporadic PD through occupational exposure. This latest study, led ...
(Date:2/24/2017)... ... February 24, 2017 , ... ... replacement options at his office, Antoine Dental Center. Currently, patients can get single ... restrictions may apply, but patients can learn more about these offers by contacting ...
(Date:2/24/2017)... , ... February 24, 2017 , ... An in-depth computational ... the University of Pittsburgh points to eight genes that may explain why susceptibility to ... to the results of a study published today in the journal npj Schizophrenia. ...
(Date:2/24/2017)... ... , ... In the Health Care IT campaign, Robert Herjavec discusses health IT ... you will be attacked, but when.” However, he and many others involved highlight a ... Improvements in auditing and monitoring have taken security in health care a very long ...
(Date:2/24/2017)... ... , ... The narrative in “ Signal 8: An Australian Paramedic’s Story ” ... paramedic experiences. Schanssema describes the tragedies he saw, as well as his struggles with ... Schanssema, initially unsure of the career path he wanted to take, found fulfillment in ...
Breaking Medicine News(10 mins):